据香港中文大学（中大）19 日公布，其医学院最近的研究发现，某些独特的肠道细菌和代谢物与接种新冠疫苗后 6 个月内对疫苗免疫持久反应有关。这表明，这些肠道微生物和代谢物可以用来标记预测新冠疫苗的长期药效。
中大医学院的这项研究结果已引起业界的高度关注，因为新冠疫苗的长期药效一直是一个备受关注的问题。该研究结果表明，新冠疫苗的长期药效可能与肠道微生物有关，这为未来研究提供了新的方向。
此外，该研究还发现，通过检测肠道微生物的代谢物，可以预测一个人对新冠疫苗的免疫反应。这为疫苗制造商提供了新的技术途径，以更好地研究疫苗的药效和安全性。
这项研究结果已在《自然》杂志上发布，并引起了全球媒体的高度关注。
英文标题：New Study Finds Key to Long-Lasting 新冠疫苗 Efficacy
关键词：新冠疫苗，肠道微生物，代谢物，长期药效
新闻内容：
A recent study published in the journal Nature has revealed a key factor in the long-lasting efficacy of vaccines. According to the study, conducted by the faculty of medicine at the University of Chinese Hong Kong, certain unique gut bacteria and metabolites are associated with a long-lasting immune response to vaccines, which can be used to predict the long-term efficacy of the vaccines.
This finding has garnered significant attention from the scientific community, as the long-lasting efficacy of vaccines has always been a topic of concern. The study suggests that the long-lasting efficacy of vaccines may be related to gut microbiota, providing a new direction for future research.
Furthermore, the study found that by monitoring the metabolites of gut microbiota, it is possible to predict an individual’s immune response to vaccines. This provides a new technical avenue for vaccine manufacturers to better understand the efficacy and safety of vaccines.
The study results have been published in the journal Nature and have attracted widespread media coverage around the world.
【来源】http://www.chinanews.com/life/2023/10-19/10096935.shtml
Views: 1